Mobile
Recherche simple
Recherche avancée
Recherche multicritère
Qui sommes-nous ?
Connexion
Inscription
French
English
Kusajili – Centralise les essais cliniques mondiaux
Résultat
de votre recherche par pays : Russian Federation
Femme et Homme Max 99 ans
nct
MAJ Il y a 4 ans
Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex
This is a multi-center, randomized, placebo-controlled, flexible-dose, parallel-group study designed to evaluate the efficacy and safety of lurasidone (in combination with lithium or dival...
Pays
Argentina
,
Australia
,
Bulgaria
,
Chile
,
Croatia
,
Czech Republic
,
France
,
Hungary
,
Japan
,
Poland
,
Russian Federation
,
Serbia
,
Slovakia
,
United States
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
nct
MAJ Il y a 4 ans
A Study of Mavrilimumab in Subjects With Moderate-to-Severe Rheumatoid Arthritis
The primary objective of this study is to evaluate the efficacy of 3 subcutaneous doses of mavrilimumab compared with placebo in combination with methotrexate (MTX) in subjects with modera...
Pays
Argentina
,
Bulgaria
,
Chile
,
Colombia
,
Czech Republic
,
Estonia
,
Germany
,
Hungary
,
Poland
,
Russian Federation
,
Serbia
,
South Africa
,
Spain
,
Ukraine
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
nct
MAJ Il y a 4 ans
Study Evaluating Long-Term Safety Of ATN-103 In Subjects With Rheumatoid Arthritis
This open-label extension study will allow subjects who have completed either the 3242K1-2000-WW or 3242K1-2001-JA study to receive up to an additional 48 weeks of ATN-103 treatment and wi...
Pays
Canada
,
Hungary
,
Japan
,
Russian Federation
,
Serbia
,
South Africa
,
Switzerland
,
United States
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
nct
MAJ Il y a 4 ans
A Study on the Effect of Renal Impairment on the Pharmacokinetics of RO4917838
This open-label, single-dose, parallel-group study will investigate the pharmacokinetics and safety of RO4917838 in healthy and renal impaired subjects. Subjects will receive a single dose...
Pays
France
,
Russian Federation
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Homme Max 99 ans
nct
MAJ Il y a 4 ans
Extension Study Investigating the Long-Term Safety of Degarelix Three-Month Depots in Patients With Prostate Cancer
The purpose of this extension study was to collect long-term safety and tolerability information to support a marketing authorisation application for a three-month dosage regimen of degare...
Pays
Belgium
,
Finland
,
France
,
Germany
,
Montenegro
,
Netherlands
,
Romania
,
Russian Federation
,
Serbia
,
United Kingdom
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
nct
MAJ Il y a 4 ans
A Randomised, Double-blind, Placebo-controlled, Parallel-group Trial to Assess Clinical Efficacy of NNC0114-0006 in Subjects With Active Rheumatoid Arthritis
This trial is conducted in Europe. The aim of the trial is to evaluate the change in disease activity following intravenous (i.v.) administration of two doses of NNC0114-0006 compared to p...
Pays
Bulgaria
,
Hungary
,
Latvia
,
Poland
,
Russian Federation
,
Serbia
,
Spain
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
nct
MAJ Il y a 4 ans
Study For Patients With Untreated Gastric Cancer Who Will Receive Capecitabine And Lapatinib
The study will determine if changes in expression of markers involved in the 5-FU pathways are associated with response to treatment with the combination of lapatinib and capecitabine inde...
Pays
Canada
,
Korea, Republic of
,
Mexico
,
Russian Federation
,
Taiwan, Province of China
,
United States
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
nct
MAJ Il y a 4 ans
Efficacy and Safety of Lanreotide Versus Placebo for Treatment of Patients With Digestive Fistulae
The purpose of the protocol, is to determine whether lanreotide 30 mg is effective in the treatment of patients with digestive fistulae.
Pays
France
,
Russian Federation
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
nct
MAJ Il y a 4 ans
Efficacy and Safety Study of Apremilast to Treat Active Ulcerative Colitis
The purpose of the study is to evaluate the clinical efficacy, safety and tolerability of apremilast (30 mg twice daily [BID] and 40 mg BID), compared with placebo, in subjects with active...
Pays
Australia
,
Bulgaria
,
Canada
,
Czech Republic
,
France
,
Germany
,
Hungary
,
Italy
,
Netherlands
,
New Zealand
,
Poland
,
Russian Federation
,
Ukraine
,
United States
Organes
Aucun
Spécialités
Aucune
Essai ouvert aux inclusions
Plus d'informations
Femme Max 99 ans
nct
MAJ Il y a 4 ans
Dose-finding Study of Empegfilgrastim for Neutropenia Prophylaxis in Patients With Breast Cancer
The purpose of the study is to compare safety and efficacy of a single dose of empegfilgrastimt a dose of 3 or 6 mg versus daily administration of filgrastim at a dose of 5 μg/kg/day.
Pays
Russian Federation
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Précédent
7
8
9
10
11
12
13
14
15
16
Suivant